You are here: Industry Insights > NVX-CoV2373

News List

Fujifilm Diosynth to Support COVID-19 Vax Candidate contractpharma
July 30, 2020
COVID-19 vaccine manufacturing capacity reserved via a task order from BARDA.
Novavax, FUJIFILM Initiate Large Scale Mfg. of COVID-19 Vax Candidate contractpharma
July 27, 2020
FUJIFILM to manufacture bulk drug substance for NVX-CoV2373 from its site in Morrisville, NC for Phase III trial.
Novavax receives $1.6bn from US Government for Covid-19 vaccine pharmaceutical-technology
July 08, 2020
Novavax has received $1.6bn under the US Government’s Operation Warp Speed (OWS) programme to support the development and manufacturing of its Covid-19 vaccine candidate.
Novavax Awarded $1.6B from Operation Warp Speed contractpharma
July 08, 2020
Supports late-stage clinical development, large-scale manufacturing of NVX-CoV2373, including production of 100 million doses starting in late 2020.
PolyPeptide Group Partners with Novavax on COVID-19 Vaccine contractpharma
June 05, 2020
Will manufacture critical intermediates of Matrix-M adjuvant for vaccine candidate.
AGC Biologics to produce Covid-19 vaccine adjuvant for Novavax pharmaceutical-technology
June 05, 2020
Novavax has selected AGC Biologics, a contract development and manufacturing organisation (CDMO), for large-scale manufacturing of an adjuvant for its Covid-19 vaccine candidate, NVX-CoV2373.
Novavax Selects AGC Biologics to Manufacture Novel COVID-19 Vax contractpharma
June 04, 2020
To provide large-scale GMP production of Matrix-M, the adjuvant component of Novavax’ coronavirus vaccine candidate, NVX-CoV2373.
Novavax launches trial of coronavirus vaccine candidate pharmatimes
May 26, 2020
As of this morning – Tuesday May 26 – the current recorded case count for COVID-19 (coronavirus) in the UK has hit 261,184 with 36,914 deaths.
CEPI invests $384m in Novavax COVID-19 vaccine candidate europeanpharmaceuticalreview
May 13, 2020
CEPI has announced that its funding for the Novavax COVID-19 vaccine candidate will go towards Phase I and Phase II trials as well as manufacturing costs.

Previous page 1 2 3 4 5 6 7 Next page